Genprex

$3.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.75%) Today

-$0.01 (-0.25%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Genprex and other stocks, options, and ETFs commission-free!

About GNPX

Genprex, Inc. Common Stock, also called Genprex, is a clinical-stage gene therapy company focused on developing potentially life-changing technologies for patients with cancer and diabetes.

CEO

J. Rodney Varner

Employees

Headquarters

Austin, Texas

Founded

2009

Market Cap

178.11M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.14M

High Today

$4.07

Low Today

$3.88

Open Price

$4.05

Volume

515.61K

52 Week High

$7.72

52 Week Low

$1.95

GNPX Earnings

-$0.14

-$0.09

-$0.05

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 28, Pre-Market